Today: 2 October 2025
29 September 2025
2 mins read

Generic Drugs Boost Hypertension Control

By setting price ceilings on essential medicines based on average market prices, India successfully kept out-of-pocket costs low while still ensuring manufacturers made sustainable profits

India’s focused public health strategies—centered on generic medicines, free drug distribution, and medicine price ceilings—have significantly improved hypertension control across the country, according to the World Health Organization (WHO). The global health body cited India’s model in its Global Report on Hypertension 2025 as an example of how targeted policy interventions can deliver measurable health gains.

Hypertension, or high blood pressure, is a leading risk factor for heart attacks and strokes, yet it often goes undiagnosed or untreated—especially in low- and middle-income countries. In India, however, recent reforms have transformed the way the condition is managed.

A key turning point was the launch of the India Hypertension Control Initiative (IHCI) in 2018-2019. The programme provided a steady supply of quality-assured, generic antihypertensive medicines in public clinics. The initiative also introduced simplified treatment protocols, trained healthcare workers, and established robust procurement systems to ensure availability at the grassroots level.

WHO noted that the National Free Drugs Service Initiative, along with Jan-Aushadhi generic medicine stores and the role of the National Pharmaceutical Pricing Authority (NPPA), played a crucial role in improving access and affordability. By setting price ceilings on essential medicines based on average market prices, India successfully kept out-of-pocket costs low while still ensuring manufacturers made sustainable profits.

This comprehensive approach is already showing results. Before these reforms, only about 14% of hypertensive adults in India had their blood pressure under control. But recent data from states like Punjab and Maharashtra show control rates as high as 70–81% among patients receiving protocol-based treatment and regular follow-up. Systolic blood pressure dropped by an average of 15–16 mmHg in these cases—an important clinical improvement.

The WHO emphasized that this is more than just a medical achievement—it’s an economic win. “Public investment in affordable, accessible antihypertensive medicines not only enhances clinical outcomes but also reduces the economic burden of cardiovascular disease,” the report stated. The prevention of strokes, heart attacks, and related complications brings a strong return on investment for the healthcare system.

Globally, the situation is still concerning. Over 1.4 billion people were living with hypertension in 2024, but only one in five had their condition under control. The WHO also found that 99 countries have national control rates below 20%, and many low-income nations lack basic access to recommended medicines.

India’s strategy stands out as a model for scalable, cost-effective public health reform. With more countries seeking to improve outcomes for non-communicable diseases, India’s success in hypertension management offers a clear roadmap for better care through policy-driven action.

Previous Story

UN Reactivates Sanctions on Iran

Next Story

Happiness and the Human Mind

Latest from Health

Lower BP Target Could Benefit Indians

Beyond salt reduction, experts stressed that controlling hypertension requires a comprehensive approach. Regular exercise, maintaining a healthy body weight, reducing alcohol intake, quitting tobacco, and consuming a balanced diet rich in fruits

Silent Diabetes Crisis Unfolds

The report further highlights that even for those who do receive a diagnosis, the challenges of care and management remain significant A startling number of young adults across the globe are living

Physiotherapists Barred From ‘Doctor’ Title

The DGHS letter cited past legal pronouncements and advisory orders from courts and councils that had already prohibited physiotherapists and occupational therapists from using the title The Directorate General of Health Services

Train ASHAs, Save Babies

Speaking to IANS, Dr. Rahul UR, State Nodal Officer – Child Health and Rare Diseases, National Health Mission, Kerala, explained that understanding the disease’s natural course is essential Training India’s network of
Go toTop

Don't Miss

Healthy and energy-filled snacks for road trip

Carrots are the perfect dipping stick that will keep you

Effective meal planning for healthy life goals

The first step to effective meal planning is to identify